Article info

Download PDFPDF
Original article
Anti-NKG2D monoclonal antibody (NNC0142-0002) in active Crohn's disease: a randomised controlled trial

Authors

  1. Correspondence to Professor Matthieu Allez, Department of Gastroenterology, Hôpital Saint-Louis, 1, Avenue Claude Vellefaux, Paris 75010, France; matthieu.allez{at}aphp.fr
View Full Text

Citation

Allez M, Skolnick BE, Wisniewska-Jarosinska M, et al
Anti-NKG2D monoclonal antibody (NNC0142-0002) in active Crohn's disease: a randomised controlled trial

Publication history

  • Received March 9, 2016
  • Revised June 30, 2016
  • Accepted July 14, 2016
  • First published August 3, 2016.
Online issue publication 
October 09, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.